Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00578994 · ClinicalTrials.gov registry record
A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System
A clinical trial of Osteoarthritis and Avascular Necrosis, sponsored by Biomet Orthopedics.
- Completed
- Registry status
- 388
- Enrollment target
- 6
- Study locations
NCT00578994: Completed study of Osteoarthritis and Avascular Necrosis, sponsored by Biomet Orthopedics.
NCT00578994 is a study of Osteoarthritis and Avascular Necrosis that has completed, run by Biomet Orthopedics. The registered enrollment target is 388 participants, below the 815-participant average among 135 other Osteoarthritis trials with a reported enrollment target (52% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00578994, a study of Osteoarthritis and Avascular Necrosis, has completed, sponsored by Biomet Orthopedics.
- COMPLETED
- Registry status
- 388 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in the United States.
Primary Outcome
Assessment of frequency of Revisions
Conditions Studied
Interventions
- DEVICE Oxford® Meniscal Unicompartmental Knee System
Study Locations (6)
Texas
- Texas Orthopedic Specialist - Bedford
- Texas Center for Joint Replacement - Plano
Illinois
- Barrington Orthopedic Specialissts - Schaumburg
Ohio
- Joint Implant Surgeons - New Albany
Tennessee
- Mid-South Orthopedic Associates - Cordova
Virginia
- Advanced Orthopaedic Centers - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 388 participants |
| Start Date | 2006-03 |
| Est. Completion | 2021-03-31 |
What the finished NCT00578994 record still lists
NCT00578994 is an observational study that tracks outcomes without assigning an intervention. The registered 388 participants enrollment target is mid-sized for trials with a published cap, below the 815-participant average among 135 other Osteoarthritis trials with a reported enrollment target (52% lower).
The record links to 2 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Oxford® Meniscal Unicompartmental Knee System is the first listed.
NCT00578994 lists 6 locations in 5 states (Texas, Illinois, Ohio).
Frequently Asked Questions
What is clinical trial NCT00578994 about?
NCT00578994 is a clinical study titled "A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System". The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in the United States.
What is the current status of trial NCT00578994?
This trial is currently completed. The enrollment target is 388 participants. The study started on 2006-03. Estimated completion is 2021-03-31.
What conditions does trial NCT00578994 study?
This clinical trial studies the following conditions: Osteoarthritis, Avascular Necrosis.
What interventions are being tested in trial NCT00578994?
The interventions under investigation include: Oxford® Meniscal Unicompartmental Knee System (DEVICE).
Who is sponsoring clinical trial NCT00578994?
This trial is sponsored by Biomet Orthopedics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00578994 being conducted?
This trial has 6 study locations across Illinois, Ohio, Tennessee, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00578994's enrollment target sits among peer trials
388 33rd of 135 higher than 103 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
RECRUITING
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
RECRUITING · Phase 4
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04092010 · 388 participants · NA
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
- NCT05157880 · 388 participants · NA
Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers
- NCT05748613 · 388 participants · NA
Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- NCT06374277 · 388 participants · NA
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia